{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:18Z","timestamp":1793384658712,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.yebeh.2018.01.011","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T01:25:13Z","timestamp":1517621113000},"page":"337-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Interventional programs to improve therapeutic management of people with epilepsy in low- and middle-income countries"],"prefix":"10.1016","volume":"80","author":[{"given":"Jeremy","family":"Jost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Maria","family":"Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Auditeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boumediene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voa","family":"Ratsimbazafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Preux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2018.01.011_bb0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"issue":"10010","key":"10.1016\/j.yebeh.2018.01.011_bb0010","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"issue":"9516","key":"10.1016\/j.yebeh.2018.01.011_bb0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","article-title":"Adult epilepsy","volume":"367","author":"Duncan","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy \u2014 a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.yebeh.2018.01.011_bb0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(14)70114-0","article-title":"Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa","volume":"13","author":"Ba-Diop","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9848","key":"10.1016\/j.yebeh.2018.01.011_bb0030","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(12)61381-6","article-title":"Epilepsy in poor regions of the world","volume":"380","author":"Newton","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuchi.2008.02.018","article-title":"Drug resistance in partial epilepsy: epidemiology, mechanisms, pharmacogenetics and therapeutical aspects","volume":"54","author":"Mann","year":"2008","journal-title":"Neurochirurgie"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2018.01.011_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1528-1157.43.s.6.13.x","article-title":"Global campaign against epilepsy: the treatment gap","volume":"43","author":"Kale","year":"2002","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2018.01.011_bb0045","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1528-1167.2008.01693.x","article-title":"The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies","volume":"49","author":"Mbuba","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1528-1157.2001.32800.x","article-title":"The treatment gap in epilepsy: the current situation and ways forward","volume":"42","author":"Meinardi","year":"2001","journal-title":"Epilepsia"},{"issue":"9848","key":"10.1016\/j.yebeh.2018.01.011_bb0055","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(12)61381-6","article-title":"Epilepsy in poor regions of the world","volume":"380","author":"Newton","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1258\/td.2010.100254","article-title":"Treatment gap for people living with epilepsy in Madagascar","volume":"41","author":"Ratsimbazafy","year":"2011","journal-title":"Trop Doct"},{"issue":"4","key":"10.1016\/j.yebeh.2018.01.011_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.09.064147","article-title":"Global disparities in the epilepsy treatment gap: a systematic review","volume":"88","author":"Meyer","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"6676","key":"10.1016\/j.yebeh.2018.01.011_bb0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.298.6676.805","article-title":"A model for managing epilepsy in a rural community in Africa","volume":"298","author":"Watts","year":"1989","journal-title":"BMJ"},{"issue":"8738","key":"10.1016\/j.yebeh.2018.01.011_bb0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0140-6736(91)91176-U","article-title":"Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya","volume":"337","author":"Feksi","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.yebeh.2018.01.011_bb0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1528-1157.1992.tb02341.x","article-title":"Prognosis of epilepsy in a rural African community: a 30-year follow-up of 164 patients in an outpatient clinic in rural Tanzania","volume":"33","author":"Jilek-Aall","year":"1992","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0920-1211(93)90048-C","article-title":"Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment","volume":"14","author":"Placencia","year":"1993","journal-title":"Epilepsy Res"},{"issue":"3 Suppl","key":"10.1016\/j.yebeh.2018.01.011_bb0090","first-page":"S18","article-title":"A survey of 100 patients in a primary health care setting in Liberia","volume":"46","author":"Voskuil","year":"1994","journal-title":"Trop Geogr Med"},{"issue":"4","key":"10.1016\/j.yebeh.2018.01.011_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/tropej\/41.4.247","article-title":"Shortcomings in the pharmacotherapy of epileptic children in Bombay, India","volume":"41","author":"Karande","year":"1995","journal-title":"J Trop Pediatr"},{"issue":"6","key":"10.1016\/j.yebeh.2018.01.011_bb0100","first-page":"633","article-title":"Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa","volume":"76","author":"Coleman","year":"1998","journal-title":"Bull World Health Organ"},{"issue":"7","key":"10.1016\/j.yebeh.2018.01.011_bb0105","first-page":"392","article-title":"Two-year remission in Nigerian epileptics","volume":"75","author":"Ogunniyi","year":"1998","journal-title":"East Afr Med J"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/004947559802800206","article-title":"Antiepileptic drug treatment in rural Africa: involving the community","volume":"28","author":"Kaiser","year":"1998","journal-title":"Trop Doct"},{"issue":"9095","key":"10.1016\/j.yebeh.2018.01.011_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0140-6736(97)06250-8","article-title":"Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India","volume":"351","author":"Pal","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1528-1157.1999.tb02072.x","article-title":"Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiologic and pharmacoeconomic study","volume":"40","author":"Radhakrishnan","year":"1999","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-1211(99)00115-1","article-title":"An evaluation of the management of epilepsy by primary health care nurses in Chitungwiza, Zimbabwe","volume":"39","author":"Adamolekun","year":"2000","journal-title":"Epilepsy Res"},{"issue":"9265","key":"10.1016\/j.yebeh.2018.01.011_bb0130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(00)04516-5","article-title":"Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study","volume":"357","author":"Mani","year":"2001","journal-title":"Lancet"},{"issue":"8\u20139","key":"10.1016\/j.yebeh.2018.01.011_bb0135","first-page":"815","article-title":"Treatment of epilepsy in rural areas in Mali","volume":"158","author":"Farnarier","year":"2002","journal-title":"Rev Neurol (Paris)"},{"issue":"7","key":"10.1016\/j.yebeh.2018.01.011_bb0140","first-page":"532","article-title":"Treatment with phenobarbital and monitoring of epileptic patients in rural Mali","volume":"80","author":"Nimaga","year":"2002","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.yebeh.2018.01.011_bb0145","first-page":"31","article-title":"Treatment of epilepsy in rural Ethiopia: 2 year follow-up","author":"Berhanu","year":"2004","journal-title":"Ethiop J Health Dev"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(05)70254-4","article-title":"Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China","volume":"5","author":"Wang","year":"2006","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2018.01.011_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0404.2007.00871.x","article-title":"Management of epilepsy patients in Batamariba district, Togo","volume":"116","author":"Balogou","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2018.01.011_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1590\/S0004-282X2007001000010","article-title":"Demonstration project on epilepsy in Brazil: outcome assessment","volume":"65","author":"Li","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1528-1167.2007.01529_2.x","article-title":"Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO\/ILAE\/IBE global campaign against epilepsy demonstration project","volume":"49","author":"Ding","year":"2008","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2018.01.011_bb0170","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1528-1167.2008.01580_2.x","article-title":"Nurse-led care for epilepsy at primary level in a rural health district in Cameroon","volume":"49","author":"Kengne","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1167.2007.01529_3.x","article-title":"The challenge of epilepsy control in deprived settings: low compliance and high fatality rates during a community-based phenobarbital program in rural Laos","volume":"49","author":"Tran","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0180","first-page":"39","article-title":"Evolution of epilepsy therapeutic gap in 6 peripheral care units in Togo","volume":"24","author":"Koffi","year":"2009","journal-title":"Mali M\u00e9d"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2018.01.011_bb0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eplepsyres.2009.01.008","article-title":"Health care delivery model in epilepsy to reduce treatment gap: World Health Organization study from a rural tribal population of India","volume":"84","author":"Nizamie","year":"2009","journal-title":"Epilepsy Res"},{"issue":"11","key":"10.1016\/j.yebeh.2018.01.011_bb0190","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3109\/03639041003758689","article-title":"Magnetic N-succinyl chitosan\/alginate beads for carbamazepine delivery","volume":"36","author":"Liu","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.seizure.2009.11.007","article-title":"Management of refractory status epilepticus at a tertiary care centre in a developing country","volume":"19","author":"Tripathi","year":"2010","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.yebeh.2018.01.011_bb0200","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1469-8749.2012.04325.x","article-title":"Prediction of seizure outcome in childhood epilepsies in countries with limited resources: a prospective study","volume":"54","author":"Banu","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2018.01.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044469","article-title":"Results of an action-research on epilepsy in rural Mali","volume":"7","author":"Bruno","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2012.06.004","article-title":"Sodium valproate for epilepsy in rural China: an efficacy and safety assessment in primary care","volume":"102","author":"Wang","year":"2012","journal-title":"Epilepsy Res"},{"issue":"11","key":"10.1016\/j.yebeh.2018.01.011_bb0215","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/epi.12382","article-title":"Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial","volume":"54","author":"Li","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0220","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yebeh.2013.08.034","article-title":"Medication adherence in patients with epilepsy after a single neurologist visit in rural India","volume":"29","author":"Bigelow","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/epi.12498","article-title":"Evaluation of Kilifi epilepsy education programme: a randomized controlled trial","volume":"55","author":"Ibinda","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2018.01.011_bb0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00916752","article-title":"Conners' teacher rating scale for use in drug studies with children \u2014 an empirical study","volume":"3","author":"Werry","year":"1975","journal-title":"J Abnorm Child Psychol"},{"issue":"1","key":"10.1016\/j.yebeh.2018.01.011_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-7610.1971.tb01047.x","article-title":"A behavioural screening questionnaire for use with three-year-old children. Preliminary findings","volume":"12","author":"Richman","year":"1971","journal-title":"J Child Psychol Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2018.01.011_bb0240","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.yebeh.2018.01.011_bb0245","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2018.01.011_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017306182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017306182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T11:58:39Z","timestamp":1535111919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017306182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":50,"alternative-id":["S1525505017306182"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.01.011","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventional programs to improve therapeutic management of people with epilepsy in low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}